Skip to main content

Table 1 Patient characteristics

From: Effects of nusinersen after one year of treatment in 123 children with SMA type 1 or 2: a French real-life observational study

SMA type

Age at treatment onset

SMN2 copy number

< 2 y

2–5 y

6–17 y

Total

2

3

4

ND

Total

Type 1a/b

10

0

0

10

6

4

0

0

10

Type 1c

11

10

3

24

7

16

0

1

24

Type 2

9

37

43

89

5

76

3

5

89

Total

30

47

46

123

18

96

3

6

123

  1. ND Not determined